| ★ | Continuous Ketone Monitoring May Guide SGLT2i Use in T1D | | 33 | Estados Unidos | |
| 11 | Diabetes Dialogue: Omnipod and AID Advancements at Insulet, With Trang Ly, PhD, MBBS | | 4.3K | Estados Unidos | 91 |
| 14 | Diabetes Dialogue: The ADA’s Statement on Diabetes Tech Integration, With Eugene Wright Jr., MD | | 584 | Estados Unidos | 91 |
| 8 | Why Glucose Alone Isn't Enough: The Future of Ketone Monitoring in Diabetes | | 475 | Estados Unidos | 92 |
| 19 | SGLT2 EN ERC Beneficio en todos los estadios | ENSEÑANDO MEDICINA INTERNA @carloswaldomi | 383 | — | 90 |
| 15 | TRIUMPH-2: Retatrutide Reduces Weight, A1C in Patients With Obesity | | 350 | Estados Unidos | 91 |
| 2 | The World’s First Dual Glucose-Ketone Monitor Receives Clearance in Europe | | 313 | Estados Unidos | 94 |
| 7 | Is Continuous Ketone Monitoring Future of Diabetes Care? | | 270 | Estados Unidos | 92 |
| 3 | Diabetes Dialogue: Tech, Screening, and Care Highlights from ADCES 2026 | | 224 | Estados Unidos | 93 |
| 4 | Diabetes Dialogue: Weekly Insulin Icodec Now Available for Type 2 Diabetes | | 206 | Estados Unidos | 93 |
| 20 | Functional Cures for T1D: Insulin Independence Through Islet Transplantation | | 185 | Estados Unidos | 90 |
| 1 | Diabetes Dialogue: CKM Systems, Triple Agonists, and a Sensor Scandal Ahead of ADA | | 179 | Estados Unidos | 96 |
| 12 | Diabetes Dialogue: Tegoprubart and Freedom from Insulin in Type 1 Diabetes | | 143 | Estados Unidos | 91 |
| 16 | Diabetes Dialogue: Evolving Wearable Insulin Delivery Devices - AID, CGM, and More | | 139 | Estados Unidos | 91 |
| 10 | Diabetes Dialogue: CONNECT, TRANSCEND, and TRIUMPH at ADA 2026 | | 114 | Estados Unidos | 91 |
| 9 | Insulin Icodec Dosing Strategies for Type 2 Diabetes | | 105 | Estados Unidos | 91 |
| 6 | Diabetes Dialogue: Diabetes Technology and Treatment in the UK, With Ketan Dhatariya, MD, PhD, MS | | 94 | Estados Unidos | 92 |
| 5 | Incretins, Monitors, and Insulin Titration at ADA 2026 | | 76 | Estados Unidos | 93 |
| 13 | Secret Shopper Study Reveals GLP-1 Telehealth Gaps | | 70 | Estados Unidos | 91 |
| 17 | Diabetes Dialogue: Teplizumab, Stelo, and Inhaled Insulin Afrezza for Pediatric Patients | | 53 | Estados Unidos | 90 |
| 18 | Converting Basal Insulin Patients to Insulin Icodec | | 49 | Estados Unidos | 90 |